Physician profile
James Maloney
NPI 1700837176
$388.49
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $36.12.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $109.27 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $51.44 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.09 | 2019 | |
| Abbott Laboratories | $34.65 | 2019-2020 | |
| Amgen INC. | $31.24 | 2019 | |
| Braemar Manufacturing, LLC | $27.46 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.29 | 2019 | |
| Astellas Pharma US INC | $22.14 | 2019 | |
| Philips North America LLC | $14.98 | 2020 | |
| Medicure Pharma INC. | $14.91 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.93 | 2019 | |
| Z-Medica, LLC | $7.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Maloney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.